The widespread use of next-generation sequencing (NGS) has revealed a large number of rare <i>PKHD1</i> variants, creating major challenges in distinguishing molecularly confirmed ARPKD from a broader spectrum of <i>PKHD1</i>-associated disease. This evidence concerns the gene PKHD1 and autosomal recessive polycystic kidney disease.